IN8bio (INAB) Metrics: History & Chart

IN8bio, Inc.(INAB)

Biotechnology · New York City, NY

$1.45+0.03 (+2.11%)

Delayed quote: Oct 6, 2026, 10:00 AM EDT

About IN8bio, Inc.

IN8bio, Inc. is a biotechnology firm currently in the clinical trial phase, dedicated to identifying, advancing, and bringing to market gamma-delta T cell-based treatments specifically for various forms of cancer. The company's primary therapeutic asset, INB-200, is an autologous (patient-derived) gamma-delta T cell product that has been genetically engineered and is presently undergoing a Phase I clinical study for glioblastoma and other solid tumor malignancies. Additionally, INB-100, an allogeneic (donor-derived) candidate, is also in a Phase I clinical trial, aiming to treat acute leukemia patients undergoing hematopoietic stem cell transplantation. Further development includes preclinical programs, INB-400 and INB-300, which are designed to address a range of solid tumor cancers. Established in 2016, the company initially operated as Incysus Therapeutics, Inc. before changing its name to IN8bio, Inc. in August 2020. Its corporate headquarters are located in New York, New York.

New York City, NY

18 employees

in8bio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: William T.

View full financials

Third-Party DCF Estimate (FMP)	$5.49
Price Gap vs Third-Party Estimate	+286.68%

7D Total Return	+14.52%
30D Total Return	+18.33%
YTD Total Return	-39.32%
1Y Total Return	-40.59%
3Y Total Return	-95.17%
5Y Total Return	-99.29%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-39.32%
2025	-69.69%
2024	-81.35%
2023	-40.26%
2022	-47.38%
2021	N/A
2020

CAGR TTM	-40.44%
CAGR 3Y	-63.57%
CAGR 5Y	-62.88%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

INAB Valuation Metrics

INAB Stock Price Metrics

INAB Dividend Metrics

INAB Growth Rate Metrics

INAB Discounted Cash Flow Metrics

INAB Returns By Period

INAB Yearly Returns

INAB Average Annual Returns By Period (CAGR)

INAB Revenue Metrics

INAB PE Ratio Metrics

INAB PS Ratio Metrics

INAB PB Ratio Metrics

INAB Price to Free Cash Flow Ratio Metrics

INAB Debt to Equity Ratio Metrics

INAB PEG Ratio Metrics

INAB FCF Yield

INAB Earnings Yield

INAB EBITDA Yield

INAB OCF Yield

INAB EV/EBIT Ratio Metrics

INAB EV/EBITDA Ratio Metrics

INAB EV/Assets Ratio Metrics

INAB EV/Sales Ratio Metrics

INAB Current Ratio Metrics

INAB Quick Ratio Metrics

INAB ROIC Metrics

INAB Return on Assets Metrics

INAB Return on Equity Metrics

INAB Net Profit Margin Metrics

INAB Gross Profit Margin Metrics

INAB Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	1.51
PB Ratio Avg TTM	0.85
PB Ratio Avg 3Y	1.23
Current VS TTM Avg	+76.72%
Current VS 3Y Avg	+22.70%
Current VS 5Y Avg	+9.95%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.12
Debt/Equity Ratio Avg TTM	0.15
Debt/Equity Ratio Avg 3Y	0.24
Current VS TTM Avg	-21.14%
Current VS 3Y Avg	-51.25%
Current VS 5Y Avg	-41.88%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.55
Ev/Assets Ratio Avg TTM	0.22
Ev/Assets Ratio Avg 3Y	0.66
Current VS TTM Avg	+144.65%
Current VS 3Y Avg	-16.94%
Current VS 5Y Avg	-18.58%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	8.21
Current Ratio Avg TTM	8.29
Current Ratio Avg 3Y	5.52
Current VS TTM Avg	-1.06%
Current VS 3Y Avg	+48.77%
Current VS 5Y Avg	+49.36%

Quick Ratio	8.21
Quick Ratio Avg TTM	8.29
Quick Ratio Avg 3Y	5.52
Current VS TTM Avg	-1.06%
Current VS 3Y Avg	+48.77%
Current VS 5Y Avg	+49.36%

ROIC	(91.74%)
ROIC Avg 3Y	(128.02%)
ROIC Avg 5Y	(106.08%)
Current VS 3Y Avg	+28.34%
Current VS 5Y Avg	+13.52%
Current VS 10Y Avg	+14.97%

ROA	(85.85%)
ROA Avg TTM	(21.19%)
ROA Avg 3Y	(25.92%)
Current VS TTM Avg	-305.12%
Current VS 3Y Avg	-231.23%
Current VS 5Y Avg	-271.01%

ROE	(101.66%)
ROE Avg TTM	(113.78%)
ROE Avg 3Y	(151.55%)
Current VS TTM Avg	+10.65%
Current VS 3Y Avg	+32.92%
Current VS 5Y Avg	+18.22%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A